UPDATE - UBS Downgraded Healthcare Realty Trust (HR) to Sell; Too Far, Too Fast

UPDATE - UBS downgraded Healthcare Realty Trust (NYSE: HR) from Neutral to Sell. PT unchanged at $16.

UBS analyst said, "We believe the rally over the past few months, fueled in part by the acquisition of Cogdell Spencer (NYSE: CSA) by Ventas (NYSE: VTR), is overdone, as HR now trades at a 32% NAV premium. HR may ultimately be an M&A candidate as the sole remaining MOB REIT, but we see no reason why a public or private buyer would pay anywhere near this premium. While we admittedly do not see a near-term catalyst, shares are more than priced for perfection, in our view, shifting the risk/reward to the downside." (UBS lowers FY12 EPS estimate to $1.27, citing more conservative development lease-up pace)

To see more ratings on HR, Click Here

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Morgan Stanley Downgrades oOh!media (OML:AU) to Equalweight
• Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral